Cannabidiol provides viable treatment opportunity formultipleneurological pathologies of autism spectrum disorder

​

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities

​

Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain

​

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders

​

A novel approach to the symptomatic treatment of autism

​

Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders

​

Targeting the endocannabinoid system in the treatment of fragile X syndrome